Literature DB >> 11148985

Use of the amplification refractory mutation system (ARMS) in the study of HbS in predynastic Egyptian remains.

A Marin1, N Cerutti, E R Massa.   

Abstract

We conducted a molecular investigation of the presence of sicklemia in six predynastic Egyptian mummies (about 3200 BC) from the Anthropological and Ethnographic Museum of Turin. Previous studies of these remains showed the presence of severe anemia, while histological preparations of mummified tissues revealed hemolytic disorders. DNA was extracted from dental samples with a silica-gel method specific for ancient DNA. A modification of the polymerase chain reaction (PCR), called amplification refractory mutation system (ARMS) was then applied. ARMS is based on specific priming of the PCR and it permits diagnosis of single nucleotide mutations. In this method, amplification can occur only in the presence of the specific mutation being studied. The amplified DNA was analyzed by electrophoresis. In samples of three individuals, there was a band at the level of the HbS mutated fragment, indicating that they were affected by sicklemia. On the basis of our results, we discuss the possible uses of new molecular investigation systems in paleopathological diagnoses of genetic diseases and viral, bacterial and fungal infections.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11148985

Source DB:  PubMed          Journal:  Boll Soc Ital Biol Sper        ISSN: 0037-8771


  3 in total

Review 1.  Sickle cell disease in Middle East Arab countries.

Authors:  Mohsen A F El-Hazmi; Ali M Al-Hazmi; Arjumand S Warsy
Journal:  Indian J Med Res       Date:  2011-11       Impact factor: 2.375

2.  Genetics and Genomic Medicine in Egypt: steady pace.

Authors:  Samia Ali Temtamy; Dalia Farouk Hussen
Journal:  Mol Genet Genomic Med       Date:  2017-01-17       Impact factor: 2.183

3.  Whole-Genome-Sequence-Based Haplotypes Reveal Single Origin of the Sickle Allele during the Holocene Wet Phase.

Authors:  Daniel Shriner; Charles N Rotimi
Journal:  Am J Hum Genet       Date:  2018-03-08       Impact factor: 11.025

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.